An employee of the German biopharmaceutical company CureVac, demonstrates research into a vaccine for coronavirus (COVID-19) at a laboratory in Tuebingen, Germany, March 12, 2020. Andreas Gebert | REUTERS CureVac raised $ 213 million in its initial public offering (IPO) in New York on Thursday, said a person familiar with …
Read More »
The enormous medical response in America to the coronavirus pandemic has not put an end to US health insurers, which doubled profits in the second quarter of 2020 compared to the same time last year. The U.S. fight against the virus has been marked by overwhelming hospitalization, testing delays and …
Read More »
Americans probably won’t have to pay for a coronavirus vaccine once researchers have one ready, according to reports. The US government intends to take the plunge for the hundreds of millions of faxed dosages that pharmaceutical companies race to produce, The Wall Street Journal reported. The interviewees also spoke reportedly …
Read More »
For the first time during the pandemic, weekly unemployment claims dipped below 1 million, but there are likely to be many more Americans eligible for unemployment benefits that were not applicable. When the $ 2 trillion CARES law was passed in March, the self-employed, self-employed, gig workers and other non-traditional …
Read More »
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »